Changing our world through 3D visualization.

The Oculenz AMD AR/XR headset (for low-vision patients) and StereoLenz 3D monitor (which allows users to see a 3D image without 3D glasses) are nearing commercialization, with seven additional products forthcoming. Reach out to get involved.

Get in Touch

The company is currently acquiring capital, collecting pre-orders, and recruiting medical and scientific boards members.

Ocutrx obtains investments through referrals, Boustead Securities, Roth Capital Partners, and our Investor Relations team. For more information, please contact us.

See our strategic alliances

Our Patents

8 Issued

Eye-tracking, AR

Visual field test, AR

Dynamic Opacity

Foveated Rendering

Telehealth Monitoring

Optical Engine

116 Pending

45 patent families

MedTiles, ORLenz, Or-Bot & Scopetrx have been filed and are pending.

160+ Expected

Additional patents have been filed on features such as micro-displays, applications, connectivity, and more.

Please reach out for more information.

Get in Touch